Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05447910Terminated
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
Breast AdenocarcinomaInvasive Breast CarcinomaResectable Breast Carcinoma
PrincipalinvestigatorStart date: 2022-07-21
NCT04249622Phase 2Terminated
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
PrincipalinvestigatorStart date: 2020-09-18
NCT03106415Phase 1/2Completed
Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer
Breast AdenocarcinomaMetastatic Triple-Negative Breast CarcinomaStage III Breast Cancer AJCC v7+4 more
PrincipalinvestigatorStart date: 2017-09-27

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lorenzo Cohen

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+21 more
Similarity Score24%

Heather Greenlee

Fred Hutch/University of Washington Cancer Consortium

Related
5 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+17 more
Similarity Score20%

Carlos E. Vargas, M.D.

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+7 more

Worked with same sponsors:

Mayo Clinic
Similarity Score10%

Timothy A Yap

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+5 more
Similarity Score8%

Banu Arun

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+5 more
Similarity Score8%

Clinton Yam

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Invasive Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
Similarity Score6%

Sarina A Piha-Paul

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Stage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7+2 more
Similarity Score5%

Joanne Mortimer

City of Hope Medical Center

Related
8 trials

Shared therapeutic areas:

Anatomic Stage III Breast Cancer AJCC v8HER2 Positive Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma+1 more
Similarity Score4%

Saranya Chumsri, MD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more

Worked with same sponsors:

Mayo Clinic
Similarity Score4%

Anand Dhruva, MD

University of California, San Francisco

Related
6 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05447910PrincipalInvestigator

Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

Breast AdenocarcinomaInvasive Breast CarcinomaResectable Breast Carcinoma
Terminated
NCT04249622Phase 2PrincipalInvestigator

Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Terminated
NCT03106415Phase 1/2PrincipalInvestigator

Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer

Breast AdenocarcinomaMetastatic Triple-Negative Breast CarcinomaStage III Breast Cancer AJCC v7+4 more
Completed

All 3 trials loaded